Onderneming IVERIC bio, Inc.
Aandelen
ISEE
US46583P1021
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 163
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Glenn Sblendorio
CEO | Chief Executive Officer | 68 | 01-07-13 |
Mark Reisenauer
PSD | President | 58 | 11-07-23 |
Xiao Ping Dai
CTO | Chief Tech/Sci/R&D Officer | - | - |
Keith Westby
COO | Chief Operating Officer | 49 | 29-01-17 |
Evelyn Harrison
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-07 |
Kathy Galante
IRC | Investor Relations Contact | - | 13-11-13 |
Corporate Officer/Principal | 49 | 02-08-21 | |
Julie Clark
PRN | Corporate Officer/Principal | - | - |
Amy Sheehan
HRO | Human Resources Officer | - | 01-01-14 |
Dhaval Desai
PRN | Corporate Officer/Principal | - | 01-01-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Glenn Sblendorio
CEO | Chief Executive Officer | 68 | 01-07-13 |
Mark Reisenauer
PSD | President | 58 | 11-07-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 137 976 851 | 137 657 408 ( 99,77 %) | 0 | 99,77 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |